232 related articles for article (PubMed ID: 23343767)
1. The impact of trisomy 21 on early human hematopoiesis.
Roy A; Cowan G; Vyas P; Roberts I
Cell Cycle; 2013 Feb; 12(4):533-4. PubMed ID: 23343767
[No Abstract] [Full Text] [Related]
2. Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia.
Mansini AP; Rubio PL; Rossi JG; Gallego MS; Medina A; Zubizarreta PA; Felice MS; Alonso CN
Arch Argent Pediatr; 2013 Dec; 111(6):532-6. PubMed ID: 24196768
[TBL] [Abstract][Full Text] [Related]
3. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation.
Anoop P; Atra A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):640. PubMed ID: 23007419
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.
Toki T; Kanezaki R; Kobayashi E; Kaneko H; Suzuki M; Wang R; Terui K; Kanegane H; Maeda M; Endo M; Mizuochi T; Adachi S; Hayashi Y; Yamamoto M; Shimizu R; Ito E
Blood; 2013 Apr; 121(16):3181-4. PubMed ID: 23440243
[TBL] [Abstract][Full Text] [Related]
5. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
[TBL] [Abstract][Full Text] [Related]
6. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review.
Miyauchi J
Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838
[TBL] [Abstract][Full Text] [Related]
7. Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature.
Yin L; Lovell MA; Wilson ML; Wei Q; Liang X
Am J Clin Pathol; 2016 Dec; 146(6):753-759. PubMed ID: 28028114
[TBL] [Abstract][Full Text] [Related]
8. Transient abnormal myelopoiesis in non-Down syndrome neonate.
Ohkawa T; Miyamoto S; Sugie M; Tomizawa D; Imai K; Nagasawa M; Morio T; Mizutani S; Takagi M
Pediatr Int; 2015; 57(1):e14-7. PubMed ID: 25711269
[TBL] [Abstract][Full Text] [Related]
9. Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21.
Hoeller S; Bihl MP; Tzankov A; Chaffard R; Hirschmann P; Miny P; Kühne T; Bruder E
Hum Pathol; 2014 May; 45(5):1003-9. PubMed ID: 24746204
[TBL] [Abstract][Full Text] [Related]
10. [Abnormal hematopoiesis in Down syndrome].
Ito E
Rinsho Ketsueki; 2014 Oct; 55(10):1738-47. PubMed ID: 25297735
[No Abstract] [Full Text] [Related]
11. Transient abnormal myelopoiesis in neonates: GATA get the diagnosis.
Bombery M; Vergilio JA
Arch Pathol Lab Med; 2014 Oct; 138(10):1302-6. PubMed ID: 25268193
[TBL] [Abstract][Full Text] [Related]
12. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
[TBL] [Abstract][Full Text] [Related]
13. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.
Alford KA; Slender A; Vanes L; Li Z; Fisher EM; Nizetic D; Orkin SH; Roberts I; Tybulewicz VL
Blood; 2010 Apr; 115(14):2928-37. PubMed ID: 20154221
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous resolution of transient abnormal myelopoiesis between 34 and 40 weeks gestation.
Maracaja DLV; Rinder H
Br J Haematol; 2020 Feb; 188(4):481. PubMed ID: 31815289
[No Abstract] [Full Text] [Related]
15. Sensitive detection of GATA1 mutations using complementary DNA-based analysis for transient abnormal myelopoiesis associated with the Down syndrome.
Mizuta S; Yamane N; Mononobe S; Watanabe A; Kitamura R; Takahara T; Matsushima C; Yoshida A; Okamoto S; Tanaka K; Iwai A; Ikegawa A; Wada T; Usami I; Maihara T; Komai T; Heike T; Nishida Y; Kobayashi K
Int J Lab Hematol; 2022 Apr; 44(2):349-355. PubMed ID: 34761527
[TBL] [Abstract][Full Text] [Related]
16. Acute megakaryoblastic leukemia with a novel GATA1 mutation in a second trimester stillborn fetus with trisomy 21.
Bonometti A; Lobascio G; Boveri E; Cesari S; Lecca M; Arossa A; Spinillo A; Errichiello E; Paulli M
Leuk Lymphoma; 2021 Sep; 62(9):2276-2279. PubMed ID: 33783296
[No Abstract] [Full Text] [Related]
17. A Case of Novel GATA-1 Mutation-positive Transient Abnormal Myelopoiesis With Life-threatening Complications in a Neonate With Down Syndrome.
Sah RR; Ray S; Bhatia P; Dhir SK; Totadri S; Kumar N; Kumar P
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e292-e295. PubMed ID: 31876781
[TBL] [Abstract][Full Text] [Related]
18. Mixed-phenotype acute leukemia, T/megakaryoblastic.
Klairmont MM; Choi JK
Blood; 2018 Nov; 132(22):2418. PubMed ID: 30498070
[No Abstract] [Full Text] [Related]
19. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
Bhatnagar N; Nizery L; Tunstall O; Vyas P; Roberts I
Curr Hematol Malig Rep; 2016 Oct; 11(5):333-41. PubMed ID: 27510823
[TBL] [Abstract][Full Text] [Related]
20. Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.
Inaba H; Londero M; Maurer SH; Onciu M; Ge Y; Taub JW; Rubnitz JE; Raimondi SC
J Clin Oncol; 2011 Mar; 29(9):e230-3. PubMed ID: 21205752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
